What you need to know about COVID-19, novel therapies for a fainting disorder and the precinct celebrates International Women’s Day – this week at the Alfred Research Alliance.
COVID-19: What you should know
Alfred Health has extensive processes in place to safely assess and manage any patients with viral infections, including the recent novel coronavirus (COVID-19).
Monash University – Central Clinical School
Monash researchers discover fainting disorder drug
Monash University researchers have revealed a novel therapy which corrects the mechanism in the body that has gone wrong in Postural Orthostatic Tachycardia Syndrome (POTS), the condition affecting the former lead singer of The Wiggles.
Grant for investigating new treatment target for chronic blood cancers
Dr Andrew Perkins, Australian Centre for Blood Diseases, has been awarded a grant from the Victorian Cancer Agency to investigate a new target for treatment of chronic blood cancers known as myeloproliferative neoplasms.
The FODMAP diet is everywhere, but researchers warn it’s not for weight loss
The FODMAP diet is used to help manage irritable bowel syndrome (IBS), but its growing popularity means exaggerated claims are being made for its benefits by so-called health gurus.
Baker Heart and Diabetes Institute
Introducing Dr Rachel Climie
In the lead up to International Women’s Day on Sunday, we want to shine a light on one of our fabulous postdoctoral researchers, Dr Rachel Climie. She is studying vascular ageing to help us understand what our large arteries can tell us about our risk of heart disease beyond the common risk factors.
Appointment of five-year Alice Baker and Eleanor Shaw Gender Equity Fellow
We are delighted to announce that our distinguished five-year Alice Baker and Eleanor Shaw Gender Equity Fellow is Dr Morag Young, a leading authority on the role of hormones in cardiovascular disease and head of the cardiovascular endocrinology laboratory at the Hudson Institute of Medical Research.
Coronavirus, a rapidly evolving global health issue (UPDATED)
The Australian Government, like others around the world, is implementing procedures aimed at reducing the spread of the coronavirus.
$6 million boost to COVID-19 public health response
Burnet and Doherty Institutes welcome Victorian Government funding boost to expedite development of new therapeutics, diagnostics, clinical research and the public health response to the novel coronavirus, COVID-19.